Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.

Vilensky JA, Duvoisin RC.

Neurology. 2011 Jan 4;76(1):105; author reply 105. doi: 10.1212/WNL.0b013e3181fac720. No abstract available.

PMID:
21205702
2.

Review: neuropathology of acute phase encephalitis lethargica: a review of cases from the epidemic period.

Anderson LL, Vilensky JA, Duvoisin RC.

Neuropathol Appl Neurobiol. 2009 Oct;35(5):462-72. doi: 10.1111/j.1365-2990.2009.01024.x. Review.

PMID:
19490429
3.

The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies.

Golbe LI, Di Iorio G, Lazzarini A, Vieregge P, Gershanik OS, Bonavita V, Duvoisin RC.

Adv Neurol. 1999;80:165-70. No abstract available.

PMID:
10410717
4.

Genetic and environmental factors in Parkinson's disease.

Duvoisin RC.

Adv Neurol. 1999;80:161-3. Review. No abstract available.

PMID:
10410716
5.

Role of genetics in the cause of Parkinson's disease.

Duvoisin RC.

Mov Disord. 1998;13 Suppl 1:7-12. Review. No abstract available.

PMID:
9613712
6.

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL.

Science. 1997 Jun 27;276(5321):2045-7.

7.

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.

Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC.

Science. 1996 Nov 15;274(5290):1197-9.

PMID:
8895469
8.

Clinical genetic analysis of Parkinson's disease in the Contursi kindred.

Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, Duvoisin RC.

Ann Neurol. 1996 Nov;40(5):767-75.

PMID:
8957018
9.

Follow-up study of risk factors in progressive supranuclear palsy.

Golbe LI, Rubin RS, Cody RP, Belsh JM, Duvoisin RC, Grosmann C, Lepore FE, Mark MH, Sachdeo RC, Sage JI, Zimmerman TR Jr.

Neurology. 1996 Jul;47(1):148-54.

PMID:
8710069
10.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS.

Neurology. 1996 Jul;47(1):1-9. Review.

PMID:
8710059
11.

Recent advances in the genetics of Parkinson's disease.

Duvoisin RC.

Adv Neurol. 1996;69:33-40. Review. No abstract available.

PMID:
8615148
12.

The clinicopathologic spectrum of Lewy body disease.

Mark MH, Dickson DW, Sage JI, Duvoisin RC.

Adv Neurol. 1996;69:315-8. No abstract available.

PMID:
8615145
13.

Kindreds of dominantly inherited Parkinson's disease: keys to the riddle.

Duvoisin RC, Golbe LI.

Ann Neurol. 1995 Sep;38(3):355-6. No abstract available.

PMID:
7668819
14.

Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.

Mark MH, Sage JI, Walters AS, Duvoisin RC, Miller DC.

Mov Disord. 1995 Jul;10(4):450-4.

PMID:
7565825
15.

Meige syndrome in the spectrum of Lewy body disease.

Mark MH, Sage JI, Dickson DW, Heikkila RE, Manzino L, Schwarz KO, Duvoisin RC.

Neurology. 1994 Aug;44(8):1432-6.

PMID:
8058144
16.

A clinical genetic study of Parkinson's disease: evidence for dominant transmission.

Lazzarini AM, Myers RH, Zimmerman TR Jr, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC.

Neurology. 1994 Mar;44(3 Pt 1):499-506.

PMID:
8145922
17.

Individualizing therapy in patients with disabling Parkinson's disease symptoms.

Calne DB, Duvoisin RC, Koller WC.

Neurology. 1994 Mar;44(3 Suppl 1):S8-11. No abstract available.

PMID:
8121579
18.

Differential diagnosis of PSP.

Duvoisin RC.

J Neural Transm Suppl. 1994;42:51-67. Review.

PMID:
7964697
19.

Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology.

Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC.

Neurology. 1993 Nov;43(11):2222-7. Review.

PMID:
8232933
20.

The genetics of Parkinson's disease. A review.

Duvoisin RC.

Adv Neurol. 1993;60:306-15. Review. No abstract available.

PMID:
8420146
21.
22.

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography.

Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR Jr, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ.

Neurology. 1992 Oct;42(10):1894-900.

PMID:
1407569
24.

Hereditary Lewy-body parkinsonism and evidence for a genetic etiology of Parkinson's disease.

Duvoisin RC, Johnson WG.

Brain Pathol. 1992 Oct;2(4):309-20. Review.

PMID:
1341965
25.

Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases.

Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC.

Neurology. 1992 Jul;42(7):1323-7.

PMID:
1620341
26.

Overview of Parkinson's disease.

Duvoisin RC.

Ann N Y Acad Sci. 1992 May 11;648:187-93. Review. No abstract available.

PMID:
1637046
27.

A brief history of parkinsonism.

Duvoisin RC.

Neurol Clin. 1992 May;10(2):301-16.

PMID:
1584174
28.

Spasmodic torticollis: the role of surgical denervation.

Duvoisin RC.

Mayo Clin Proc. 1991 Apr;66(4):433-5. No abstract available.

PMID:
2013994
29.

Anxiety disorders in familial parkinsonism.

Lauterbach EC, Duvoisin RC.

Am J Psychiatry. 1991 Feb;148(2):274. No abstract available.

PMID:
1987832
30.

A large kindred with autosomal dominant Parkinson's disease.

Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC.

Ann Neurol. 1990 Mar;27(3):276-82.

PMID:
2158268
31.

Clinically atypical expression of pathologically typical Lewy-body parkinsonism.

Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC.

Clin Neuropharmacol. 1990 Feb;13(1):36-47.

PMID:
1689615
32.

Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'.

McHale DM, Sage JI, Sonsalla PK, Heikkila RE, Duvoisin RC.

Eur Neurol. 1990;30(2):90-2.

PMID:
2340841
33.

Autosomal dominant Lewy-body Parkinson's disease.

Golbe LI, Miller DC, Duvoisin RC.

Adv Neurol. 1990;53:287-92. No abstract available.

PMID:
2173372
34.

Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.

Sage JI, Sonsalla PK, McHale DM, Heikkila RE, Duvoisin RC.

Adv Neurol. 1990;53:383-6. No abstract available.

PMID:
2122646
35.

New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation.

Duvoisin RC.

Neurology. 1989 Nov;39(11 Suppl 2):4-6. Review. No abstract available.

PMID:
2573862
36.

Magnetic stimulation in the diagnosis of lumbosacral radiculopathy.

Chokroverty S, Sachdeo R, Dilullo J, Duvoisin RC.

J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):767-72.

37.

Toward a definition of Parkinson's disease.

Duvoisin RC, Golbe LI.

Neurology. 1989 May;39(5):746. No abstract available.

PMID:
2710369
38.

Seizures in progressive supranuclear palsy.

Nygaard TG, Duvoisin RC, Manocha M, Chokroverty S.

Neurology. 1989 Jan;39(1):138-40.

PMID:
2909902
39.

Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism.

Golbe LI, Miller DC, Duvoisin RC.

Mov Disord. 1989;4(2):147-52.

PMID:
2543919
40.

Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy.

Duvoisin RC, Nicklas WJ, Ritchie V, Sage J, Chokroverty S.

J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1508-11.

41.

Supranuclear disturbances of ocular motility in Lytico-Bodig.

Lepore FE, Steele JC, Cox TA, Tillson G, Calne DB, Duvoisin RC, Lavine L, McDarby JV.

Neurology. 1988 Dec;38(12):1849-53.

PMID:
3194062
42.

Risk factors for progressive supranuclear palsy.

Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS.

Neurology. 1988 Oct;38(10):1546-52.

PMID:
3419596
43.

Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism.

Sage JI, Trooskin S, Sonsalla PK, Heikkila R, Duvoisin RC.

Ann Neurol. 1988 Jul;24(1):87-9.

PMID:
3415201
44.

Prevalence and natural history of progressive supranuclear palsy.

Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC.

Neurology. 1988 Jul;38(7):1031-4.

PMID:
3386818
45.

Isolated jejunal pouches for levodopa delivery in parkinsonian patients with "on-off". Successful experimental model in dogs.

Sage JI, Trooskin S, Schuh L, Duncsak P, Sonsalla PK, Heikkila RE, Manzino L, Reddell M, Duvoisin RC.

Clin Neuropharmacol. 1988 Jun;11(3):212-20.

PMID:
3401857
46.

Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.

Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE.

Eur J Pharmacol. 1988 Feb 9;146(2-3):313-8.

PMID:
3131149
47.

Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.

Sage JI, Schuh L, Heikkila RE, Duvoisin RC.

Clin Neuropharmacol. 1988 Feb;11(1):36-44.

PMID:
3349496
48.

Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease.

Golbe LI, Lieberman AN, Muenter MD, Ahlskog JE, Gopinathan G, Neophytides AN, Foo SH, Duvoisin RC.

Clin Neuropharmacol. 1988 Feb;11(1):45-55.

PMID:
3127050
49.

Dopa-responsive dystonia.

Nygaard TG, Marsden CD, Duvoisin RC.

Adv Neurol. 1988;50:377-84. Review.

PMID:
3041760
50.

Progressive supranuclear palsy.

Duvoisin RC, Golbe LI, Lepore FE.

Can J Neurol Sci. 1987 Aug;14(3 Suppl):547-54. Review.

PMID:
3315157

Supplemental Content

Loading ...
Support Center